Angela Hildreth

Angela Hildreth has been appointed Chief Financial Officer and Board Director at hVIVO plc, effective November 18, 2026. She succeeds interim CFO Richard Cotton, who will resume his position as a non-executive director after a handover. Hildreth brings more than 15 years of strategic and operational experience in listed healthcare companies. She established her career in life sciences during her 7-year journey at Shield Therapeutics, navigating investment stages, raising capital, and commercialising products.

Born in January 1980, Hildreth is British and resides in England. She pursued A Levels and initially planned to study Biomedical Sciences at university but chose to enter the workforce instead, working her way up through various companies. Prior to joining Futura Medical, her experience was focused on corporate finance before she entered the pharmaceuticals sector.

Career History

• Finance Director and Chief Operating Officer at Futura Medical plc (2018-2026)
• UK Finance Director at Shield Therapeutics plc, helping develop its financial and operational capabilities ahead of its AIM listing in 2016 (2011-2017)
• Non-executive roles at Aptamer Group plc (2016-2023)

What Angela Hildreth could bring to Chief Financial Officer at hVIVO plc: Her track record in guiding businesses through operational growth, commercialisation and regulatory milestones positions her to capitalise on hVIVO's strong commercial momentum and expanding clinical development platform. She is expected to support the company's strategy for sustainable, profitable growth and long-term shareholder value.